FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill

On Nov. 30, the FDA's Antimicrobial Drugs Advisory Committee voted to endorse Merck's molnupiravir pill for use in treating COVID-19 in high-risk adults

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting